Your browser doesn't support javascript.
loading
Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.
Skowronski, Danuta M; Chambers, Catharine; Sabaiduc, Suzana; Dickinson, James A; Winter, Anne-Luise; De Serres, Gaston; Drews, Steven J; Jassem, Agatha; Gubbay, Jonathan B; Charest, Hugues; Balshaw, Robert; Bastien, Nathalie; Li, Yan; Krajden, Mel.
Afiliação
  • Skowronski DM; British Columbia Centre for Disease Control, Vancouver, Canada.
  • Chambers C; University of British Columbia, Vancouver, Canada.
  • Sabaiduc S; British Columbia Centre for Disease Control, Vancouver, Canada.
  • Dickinson JA; British Columbia Centre for Disease Control, Vancouver, Canada.
  • Winter AL; University of Calgary, Calgary, Canada.
  • De Serres G; Public Health Ontario, Toronto, Canada.
  • Drews SJ; Institut National de Santé Publique du Québec (National Institute of Health of Quebec), Québec, Canada.
  • Jassem A; Laval University, Quebec, Canada.
  • Gubbay JB; Centre Hospitalier Universitaire de Québec (University Hospital Centre of Quebec), Québec, Canada.
  • Charest H; Alberta Provincial Laboratory, Edmonton, Canada.
  • Balshaw R; University of Alberta, Edmonton, Canada.
  • Bastien N; British Columbia Centre for Disease Control, Vancouver, Canada.
  • Li Y; University of British Columbia, Vancouver, Canada.
  • Krajden M; Public Health Ontario, Toronto, Canada.
Euro Surveill ; 22(6)2017 Feb 09.
Article em En | MEDLINE | ID: mdl-28205503

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / Vírus da Influenza A Subtipo H3N2 / Potência de Vacina Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / Vírus da Influenza A Subtipo H3N2 / Potência de Vacina Idioma: En Ano de publicação: 2017 Tipo de documento: Article